PowerPoint Presentation
|
1_Introduction_Welcome_BALTAS.pdf |
1 |
|
3_ Rivard - Tx Delivery technologies v3 |
9 |
|
4_Baltas The Principles of Imaging based Treatment Planning |
58 |
|
6_LB - Tissue Segmentation and Characterization |
110 |
|
7_QA Imaging BT. J Perez-Calatayud |
161 |
|
8_ReconstructionandSourceLoc_Nesvacil |
219 |
|
1 PP - Monte Carlo.pdf |
278 |
|
2_Rivard - TG-43 |
330 |
|
3_LB - Limitations of TG-43 |
368 |
|
4_PP - ACE |
451 |
|
5_PP - ACUROS |
498 |
|
6_LB - Intro Commissioning |
537 |
|
7_PP - summary and close up |
583 |
|
1_Dose Evaluation J. Perez-Calatayud.pdf |
614 |
|
2_Prescribing_Nesvacil |
671 |
|
3_Baltas Optimization and Inverse Planning |
724 |
|
6_Rivard - source strength determinations |
786 |
|
7_PP - Experimental Dosymetry |
843 |
|
8_Baltas Treatment Delivery Verification |
909 |
|
9_LB - In Vivo Dosimetry |
958 |
|
1_Uncertainties_Nesvacil.pdf |
1019 |
|
2_Rivard - QMP Elements |
1083 |
|
3_LB - FutureI-Tracking Tech |
1145 |
|
4_Rivard - Future Perspectives II |
1208 |